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Abstract 
Introduction 
Our objective was to investigate whether a lack of frizzled-related protein B (FrzB), an 
extracellular antagonist of the Wnt signaling pathways, could enhance cartilage degradation 
by facilitating the expression, release and activation of matrix metalloproteinases (MMPs) by 
chondrocytes in response to tissue-damaging stimuli. 
Methods 
Cartilage explants from FrzB−/− and wild-type mice were challenged by excessive dynamic 
compression (0.5 Hz and 1 MPa for 6 hours). Load-induced glycosaminoglycan (GAG) 
release and MMP enzymatic activity were assessed. Interleukin-1β (IL-1β) (10, 100 and 1000 
pg/mL for 24 hours) was used to stimulate primary cultures of articular chondrocytes from 
FrzB−/− and wild-type mice. The expression and release of MMP-3 and −13 were determined 
by RT-PCR, western blot and ELISA. The accumulation of β-catenin was assessed by RT-
PCR and western blot. 
Results 
Cartilage degradation, as revealed by a significant increase in GAG release (2.8-fold, P = 
0.014) and MMP activity (4.5-fold, P = 0.014) by explants, was induced by an excessive 
load. Load-induced MMP activity appeared to be enhanced in FrzB−/− cartilage explants 
compared to wild-type (P = 0.17). IL-1β dose-dependently induced Mmp-13 and −3 gene 
expression and protein release by cultured chondrocytes. IL-1β-mediated increase in MMP-
13 and −3 was slightly enhanced in FrzB−/− chondrocytes compared to wild-type (P = 0.05 
and P = 0.10 at gene level, P = 0.17 and P = 0.10 at protein level, respectively). Analysis of 
Ctnn1b and Lef1 gene expression and β-catenin accumulation at protein level suggests that 
the enhanced catabolic response of FrzB−/− chondrocytes to IL-1β and load may be associated 
with an over-stimulation of the canonical Wnt/β-catenin pathway. 
Conclusions 
Our results suggest that FrzB may have a protective role on cartilage degradation and MMP 
induction in mouse chondrocytes by attenuating deleterious effects of the activation of the 
canonical Wnt/β-catenin pathway. 
Introduction 
Osteoarthritis (OA) is a common multifactorial joint disease, with ageing and excessive 
loading as important risk factors. Although the pathophysiology of OA involves cartilage, 
bone and the synovial tissue, the main feature of OA remains the progressive degradation of 
articular cartilage. Progressive joint destruction in OA has been associated with over-
activation of Wnt signaling in numerous studies [1-6]. The Wnt signaling pathway is a potent 
regulator of bone and cartilage homeostasis and also has a role in human joint diseases [7,8]. 
The canonical Wnt pathway is initiated by binding of Wnt ligands to frizzled receptors and 
co-receptors “low-density lipoprotein receptors” (LRP-5/6), which leads to intracellular β-
catenin stabilization and accumulation, nuclear translocation, interaction with transcription 
factors, T-cell factor and lymphoid enhancer binding factor (TCF/LEF), and finally activation 
of target genes. The non-canonical Wnt pathways involve specific ligands and are 
independent of β-catenin and LRPs. Wnt ligands such as Wnt-7b, Wnt-16 and Wnt target 
gene “Wnt-1 inducible signaling pathway protein 1” (Wisp-1) were found up-regulated in OA 
cartilage [1-3]. In addition, β-catenin, the co-receptor LRP-5 and the transcription factor 
LEF-1 were found over-expressed [4-6]. FrzB (Frizzled-related protein) is an extracellular 
antagonist of the Wnt signaling pathway, also called secreted Frizzled-related protein 3 
(sFRP-3). As FrzB can bind Wnts in the extracellular space and prevent ligand-receptor 
interaction, it can be considered an antagonist of both canonical and non-canonical signaling. 
Two single nucleotide polymorphisms in FRZB, which are loss-of-function mutations, were 
associated with an increased risk of OA [9-13]. However, this association was challenged by 
recent studies [14-17], so that the potential role of FrzB in OA is still controversial. 
Studies in mouse models of OA corroborated the association between cartilage degradation 
and an over-activation of Wnt signaling. In particular, Wisp-1 was found up-regulated in 2 
models of OA; moreover, local over-expression of Wisp-1 enhanced cartilage damage [3]. 
Transgenic mice that produced activated-β-catenin in adult chondrocytes developed an OA-
like phenotype upon ageing [4]. FrzB−/− knockout mice did not develop spontaneous OA, 
however the deletion of FrzB increased cartilage loss in 3 different models of arthritis [18]. 
Thus, FrzB may have a protective role on OA progression. How FrzB can influence OA 
process remains largely unclear, but various hypotheses have been suggested [4,18-22]. The 
canonical Wnt pathway is crucial for proper chondrocyte differentiation in early 
developmental processes to control chondrogenesis and later, to regulate hypertrophic 
maturation. Abnormal Wnt signaling in the absence of FrzB could cause aberrant skeletal 
morphogenesis and variations in human hip shape have been associated with the above-
mentioned FrzB polymorphisms [19]. This could contribute to the development of OA by 
increasing the biomechanical burden on the articular cartilage [19,23]. In addition, OA is also 
characterized by hypertrophy-like changes in chondrocytes, which could be enhanced by an 
over-activation of Wnt signaling in absence of FrzB [24]. 
In cultured chondrocytes, Wnt-3a, a commonly used Wnt ligand that triggers β-catenin 
signaling, increased the expression of MMP-3 and −13, and MMP-2 and −9 enzymatic 
activities [25-27]. In transgenic mice, activated-β-catenin increases the expression of MMP-2, 
−3, −7, −9 and −13 [4,28]. Similarly, down-regulation of LRP-5 decreased the expression of 
MMP-7, −9, −13 and −14 [5,6]. The transcription complex formed by activated-β-catenin and 
Lef-1 has been shown to strongly bind MMP-9, −13 and −14 promoters, especially [5,29]. 
We focused on the hypothesis that the absence of FrzB could favor OA-like catabolic 
processes in cartilage by increasing the activation of the Wnt signaling pathway. We 
therefore studied cartilage degradation in FrzB KO mice, after biomechanical loading or 
cytokine treatment. 
Methods 
Animals 
All experiments were made on explants or primary chondrocytes extracted from 3 to 6-day-
old newborn litters from FrzB−/− or wild-type mice [18]. All procedures were in accordance 
with the European Directive N886/609 and were performed according to the protocols 
approved by French and European ethics committees for animal use and care (Comité 
Régional d’Ethique en Expérimentation Animale N°3 de la région Ile de France). 
Compression of costal cartilage explants 
The procedure for compressive loading of mouse costal cartilage explants was as described 
[30]. Briefly, explants were harvested from rib cages of 4- to 6-day-old newborn mice. 
Samples were cleaned, divided into segments, pooled and weighed for further normalization; 
each sample consisted of around 30–40 mg of costal cartilage. The explants were allowed to 
rest for about 20 h in 3 mL of serum-free medium (DMEM medium supplemented with 0.1% 
bovine serum albumin and 30 mM Hepes). They were washed before they underwent 6-h 
dynamic compression in 1.5 mL of the same fresh medium (sinusoidal wave-form 0–1 MPa 
at 0.5 Hz) by the Biopress system (Flexercell International, Dunn Labortechnick GmbH, 
Asbach, Germany). Control explants were kept in unloaded conditions. After the application 
of the mechanical regimen, supernatants and cartilage explants were collected and stored 
immediately at −80°C. Our results are expressed as fold-induction versus the uncompressed 
explants controls. 
Primary culture of mouse articular chondrocytes 
Primary chondrocytes were isolated from articular cartilage of 4- to 6-day-old newborn mice 
as described [31]. After 1 week of expansion, the cells were placed in serum-free conditions 
for 24 h (0.1% bovine serum albumin, Sigma Aldrich, Saint-Quentin Fallavier, France), then 
treated for 24 h in serum-free medium supplemented with 0, 10, 100 or 1000 pg/mL IL-1β 
(PeproTech, Tebu-Bio, Le Peray-en-Yvelines, France). Our results are expressed as fold-
induction versus the non-treated controls. 
RNA extraction, RT and real-time PCR 
RNA was extracted from chondrocytes cultured with and without IL-1β by use of the RNeasy 
minikit (Qiagen, Courtaboeuf, France); for the RNA extraction from compressed and 
uncompressed cartilage explants, Proteinase K (Qiagen) was first added to remove proteins as 
suggested for tissue samples by the manufacturer (Proteinase K, Qiagen). Reverse 
transcription was performed on 1 µg RNA for monolayer-cultured cells and 100–200 ng RNA 
for explants by use of the Omniscript kit (Qiagen). Relative quantification of genes involved 
use of the LC480 LightCycler Real Time PCR system (Roche Applied Science, Meylan, 
France) and Go Taq QPCR master mix (Promega, Charbonnières les Bains, France). mRNA 
levels of MMP-3 and −13, β-catenin (Ctnnb1) and Lef1 were normalized to that of 
hypoxanthine-guanine phosphoribosyltransferase (Hprt), used as internal standard. 
Mmp-3 s-TGAAAATGAAGGGTCTTCCGG; as-GCAGAAGCTCCATACCAGCA, 
Mmp-13 s-GATGGCACTGCTGACATCAT; as-TGTAGCCTTTGGAACTGCTT, 
Ctnnb1 s-GCAGCAGCAGTTTGTGGA; as-TGTGGAGAGCTCCAGTACACC, 
Lef1 s-TCCTGAAATCCCCACCTTCT; as-TGGGATAAACAGGCTGACCT, 
Hprt s-AGGACCTCTCGAAGTGT; as-ATTCAAATCCCTGAAGTACTCAT. 
MMP-3 and −13 protein measurement 
The amount of MMP-3 and −13 released by chondrocytes in response to IL-1β was assessed 
in the culture supernatants. For total mouse MMP-3 secretion we used a commercially 
available ELISA kit (R&D systems, Lille, France). For total mouse MMP-13 secretion we 
performed western blot analysis as described [32] with rabbit polyclonal antibody for MMP-
13 (H-230) (Santa Cruz Biotechnology, Tebu-Bio, Le Peray-en-Yvelines, France). 
Densitometry analysis of immunoblots involved use of Multi Gauge software (Fujifilm, Paris, 
France). 
GAG and MMP enzymatic activity assays 
Amount of GAG and global MMP activity were measured in the culture supernatants of 
compressed cartilage explants. GAG released was assessed by reaction with 
dimethylmethylene blue [33]. Shark chondroitin sulfate was used as a standard. MMP activity 
was assessed by Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 synthetic fluorogenic substrate 
(Bachem, Weil am Rhein, Germany) in continuous assays [34]. Results were normalized to 
milligram wet weight cartilage and concentration of proteins in the culture supernatant. 
β-catenin accumulation 
Intracellular proteins were extracted from chondrocytes cultured with and without IL-1β. 
Assay of total mouse β-catenin involved western blot analysis with rabbit polyclonal antibody 
for β-catenin (Cell Signaling, Danvers, Massachusetts). A re-probing with anti-β-actin 
antibodies (AC-15) (Sigma Aldrich) served as a loading control. Densitometry analysis of 
immunoblots involved use of Multi Gauge software (Fujifilm, Paris, France). The ratio of β-
catenin band intensity to the β-actin band intensity was calculated. 
Statistical analysis 
Data are expressed as mean ± SEM and were analyzed by the use of Mann–Whitney non-
parametric tests. 3 to 4 independent experiments were performed. P values (p) and number of 
experiments (n) are indicated in the figure legends. 
Results 
Load-induced catabolism is enhanced in FrzB−/− cartilage 
Cartilage explants from FrzB−/− and wild-type mice were stimulated by dynamic compression 
for 6 h. As previously published by our group, load induced cartilage degradation in the 
explants [35]. Cartilage degradation was revealed by a net increase in GAG release (2.8-fold, 
p = 0.014, Figure 1A) and MMP activity (4.5-fold, p = 0.014, Figure 1B). At baseline, 
cartilage degradation was not different between the FrzB−/− and wild-type samples (data not 
shown). Load-induced GAG release was similar in FrzB−/− and wild-type samples but load-
induced increase in MMP activity was slightly enhanced in FrzB−/− cartilage explants 
compared to wild-type (1.6-fold, p = 0.17, Figure 1B). Thus, the lack of FrzB tends to 
enhance the catabolic response of chondrocytes in situ, in response to mechanical stress. 
Figure 1 Load-induced GAG release and MMP activity in mouse cartilage explants 
from FrzB−/− and wild-type (WT) mice. Explants were subjected to dynamic compression 
for 6 h (0.5 Hz, 1 MPa). FrzB−/− cartilage explants (black bars, n = 4) or WT ones (grey bars, 
n = 4) were loaded. Results from the loaded cartilage explants were normalized to the ones 
from the corresponding non-loaded explants (Ctrl), so that the graphs represent the fold-
induction in response to compression. A, Amount of glycosaminoglycan (GAG) released 
from cartilage explants into culture supernatant. B, MMP enzymatic activity was measured in 
the culture supernatant of cartilage explants. Load-induced MMP activity tends to be 
enhanced in FrzB−/− explants compared to WT (p = 0.17). Bars represent the mean ± SEM, * 
p ≤ 0.05 versus Ctrl. 
IL-1β-mediated MMP induction is enhanced in FrzB−/− chondrocytes 
Primary cultures of articular chondrocytes from FrzB−/− and wild-type mice were stimulated 
with increasing doses of IL-1β for 24 h (10, 100 and 1000 pg/mL). IL-1β dose-dependently 
induced Mmp-13 gene expression (up to 15-fold, p = 0.05, Figure 2A). At the higher dose, 
IL-1β-induced Mmp-13 gene expression was enhanced in FrzB−/− chondrocytes compared to 
wild-type (p = 0.05). Of note, in basal conditions, Mmp-13 gene expression was similar in 
FrzB−/− and wild-type chondrocytes (0.012 ± 0.008 versus 0.020 ± 0.008 arbitrary units, 
respectively). At protein level, MMP-13 release was measured by western blot analysis 
(Figure 2B). MMP-13 release was not modulated by the lower doses of IL-1β, but was 
significantly increased in response to 1000 pg/mL (p = 0.014). This increase in MMP-13 
release tended to be slightly enhanced in FrzB−/− chondrocytes compared to wild-type (1.5-
fold, p = 0.17). Similarly, IL-1β dose-dependently induced Mmp-3 gene expression (up to 
500-fold, p = 0.05, Figure 3A). At the higher dose, IL-1β-induced Mmp-3 gene expression 
tended to be enhanced in FrzB−/− chondrocytes compared to wild-type (p = 0.10). Alike for 
Mmp-13, Mmp-3 gene expression was similar in FrzB−/− and wild-type chondrocytes in basal 
conditions (0.0021 ± 0.0010 versus 0.0017 ± 0.0004 arbitrary units, respectively). At protein 
level, MMP-3 release was assessed by ELISA (Figure 3B). MMP-3 was not detected in 
untreated conditions, but only in response to the higher doses of IL-1β (p = 0.05). MMP-3 
release in response to 100 pg/mL of IL-1β was enhanced in FrzB−/− chondrocytes compared 
to wild-type (2.1 fold, p = 0.10). Thus, the absence of FrzB tends to enhance the catabolic 
response of cultured chondrocytes, in response to a pro-inflammatory stress. These results are 
parallel to the enhanced catabolic response observed in loaded FrzB−/− cartilage explants. 
Figure 2 IL-1β-mediated increase in MMP-13 in cultured articular chondrocytes is 
enhanced in absence of FrzB. Primary chondrocytes were treated for 24 h with IL-1β (10, 
100 or 1000 pg/mL). Results from the treated chondrocytes were normalized to the ones from 
non-treated samples (Ctrl), so that the graphs represent the fold-induction in response to IL-
1β. A, Real-time PCR analysis of Mmp-13 gene expression. IL-1β-induced Mmp-13 gene 
expression tends to be enhanced in FrzB−/− chondrocytes compared to WT, especially with 
1000 pg/mL (p = 0.05, n = 3). B, Culture media were analyzed for MMP-13 by Western-
blotting. Quantification of MMP-13 blot is shown below the blot. IL-1β-induced MMP-13 
protein release tends to be enhanced in FrzB−/− chondrocytes compared to WT, especially 
with 1000 pg/mL (p = 0.17, n = 4). Bars represent the mean ± SEM, * p ≤ 0.05 versus Ctrl, # 
p ≤ 0.10 between FrzB−/− and WT, ND = not detected. 
  
Figure 3 IL-1β-mediated increase in MMP-3 in cultured articular chondrocytes is 
enhanced in absence of FrzB. Primary chondrocytes were treated for 24 h with IL-1β (10, 
100 or 1000 pg/mL). A, Real-time PCR analysis of Mmp-3 gene expression. Results from the 
treated chondrocytes were normalized to the ones from non-treated samples (Ctrl), so that the 
graphs represent the fold-induction in response to IL-1β. IL-1β-induced Mmp-3 gene 
expression tends to be enhanced in FrzB−/− chondrocytes compared to WT, especially with 
1000 pg/mL (p = 0.10, n = 3). B, Culture media were analyzed for total MMP-3 by ELISA. 
MMP-3 protein release in response to 100 pg/mL of IL-1β tends to be enhanced in FrzB−/− 
chondrocytes compared to WT (p = 0.10, n = 3). Bars represent the mean ± SEM. * p ≤ 0.05 
versus Ctrl, # p ≤ 0.10 between FrzB−/− and WT, ND = not detected. 
IL-1β- and load-induced catabolism in FrzB−/− chondrocytes is associated with 
canonical Wnt/β-catenin signaling 
We wondered if the enhancement in the response of FrzB−/− chondrocytes to IL-1β and load 
was associated with a deregulation in Wnt/β-catenin signaling. In basal conditions, Ctnnb1 
gene expression (coding β-catenin) was comparable between FrzB−/− cultured chondrocytes 
and wild-type ones (0.62 ± 0.22 versus 0.95 ± 0.12 arbitrary units, respectively). Of note, 
similar results were observed for the Wnt/β-catenin target gene Lef1 (0.031 ± 0.009 for wild-
type versus 0.018 ± 0.013 for FrzB−/− chondrocytes). These data are in accordance with the 
previous transcriptome analysis of the Bone-Cartilage unit of FrzB−/− mice : at baseline in 
vivo, Ctnnb1 mRNA level was not different between the FrzB−/− and wild-type strain [36]. 
Ctnnb1 gene expression was not affected by IL-1β in wild-type cultured chondrocytes (Figure 
4A). In IL-1β-treated FrzB−/− chondrocytes, Ctnnb1 gene expression was induced 4.3-fold 
compared to untreated ones (p = 0.014). Thus, Ctnnb1 gene expression was markedly higher 
in IL-1β-treated FrzB−/− chondrocytes compared to wild-type ones (3.6 fold, p = 0.057). In 
parallel, Lef1 gene expression was induced 6.2-fold in IL-1β-treated FrzB−/− chondrocytes 
compared to untreated ones (p = 0.05) and Lef1 mRNA level was clearly higher in IL-1β-
treated FrzB−/− chondrocytes compared to wild-type ones (13 fold, p = 0.05, Figure 4A). 
Analysis of β-catenin accumulation at protein level did not strictly correlate this 
transcriptional regulation (Figure 4B). IL-1β tended to decrease β-catenin content of wild-
type cultured chondrocytes (20% less, p = 0.057), whereas no modulation was observed in 
FrzB−/− ones. Thus, β-catenin content was higher in IL-1β-treated FrzB−/− chondrocytes 
compared to wild-type ones (1.4 fold, p = 0.10). IL-1β only slightly modulates Wnt/β-catenin 
signaling in our model, but a FrzB-dependent deregulation was observed in IL-1β-treated 
chondrocytes. 
Figure 4 IL-1β- and load-mediated regulation of Wnt/β-catenin signaling in 
chondrocytes from FrzB−/− and wild-type (WT) mice. A, B, Cultured articular 
chondrocytes from FrzB−/− mice or WT ones were treated for 24 h with IL-1β (1 ng/mL). 
Results from the IL-1β-treated samples were normalized to the control ones (Ctrl), so that the 
graphs represent the fold-induction in response to IL-1β. A, Ctnnb1 gene expression (coding 
β-catenin) and Lef1 gene expression (a Wnt/β-catenin target gene) were analyzed by real-time 
PCR (n = 4 and n = 3, respectively). Ctnnb1 gene expression was not modulated by IL-1β in 
WT chondrocytes and Lef1 gene expression was decreased (p = 0.05). In contrast, the 
treatment induced Ctnnb1 and Lef1 gene expression in FrzB−/− chondrocytes (p = 0.014 and p 
= 0.05, respectively). Thus IL-1β-mediated regulation of β-catenin expression was different 
between FrzB−/− and WT (p = 0.057 for Ctnnb1, p = 0.05 for Lef1). B, Intracellular extracts 
were analyzed for total β-catenin by Western-blotting. Quantification of β-catenin blot 
suggested that IL-1β-mediated β-catenin accumulation was different between FrzB−/− and WT 
(p = 0.10, n = 4). C, FrzB−/− cartilage explants or WT ones were subjected to dynamic 
compression for 6 h (0.5 Hz, 1 MPa). Ctnnb1 gene expression was analyzed by real-time 
PCR (n = 3). Results from the loaded cartilage explants were normalized to the ones from the 
corresponding non-loaded explants (Ctrl), so that the graphs represent the fold-induction in 
response to compression. Ctnnb1 gene expression was not affected by load in WT explants 
but was increased 2.7-fold in compressed FrzB−/− samples (p = 0.05). Load-induced increase 
in Ctnnb1 mRNA tends to be enhanced in FrzB−/− explants compared to WT (p = 0.20). Bars 
represent the mean ± SEM, * p ≤ 0.05 versus Ctrl, # p ≤ 0.10 between FrzB−/− and WT. 
Concerning the catabolic response of FrzB−/− cartilage to load, analysis of Ctnnb1 gene 
expression showed very similar results (Figure 4C). Ctnnb1 mRNA level was not affected by 
compression in wild-type explants. In compressed FrzB−/− samples, Ctnnb1 gene expression 
was induced 2.7-fold compared to uncompressed ones (p = 0.05). Thus, the modulation in 
Wnt/β-catenin signaling in response to load was slightly enhanced in FrzB−/− cartilage (p = 
0.20, Figure 4C). 
Overall, these results suggest that the enhancement in the response of FrzB−/− chondrocytes to 
IL-1β and load may be associated with an over-stimulation of the canonical Wnt pathway. 
Discussion 
Enhanced responsiveness to mechanical stress in absence of FrzB and 
involvement of canonical Wnt/β-catenin pathway 
We demonstrated here that load-induced MMP activity was enhanced in FrzB−/− cartilage 
explants. In addition, load stimulated Ctnnb1 gene expression in FrzB−/− explants. These 
results suggest that the load-induced catabolic response of chondrocytes may be in part 
mediated by the canonical Wnt pathway. The involvement of Wnt signaling in osteoblast 
responsiveness to mechanical stimulation was proven in various studies [37-42]. In particular, 
TOPGAL reporter mice showed that the canonical Wnt/β-catenin pathway was activated by 
mechanical stress in vivo and in cultured osteoblasts [43]. Furthermore, increasing basal β-
catenin levels was shown to enhance the effects of mechanical stress [44]. Chondrocyte 
responses towards mechanical stimulation have been less studied. However, pressure-induced 
mechanical stress triggered β-catenin tyrosine phosphorylation in cultured chondrocytes [45] 
thereby likely releasing the molecule from adherens junctions and increasing its availability 
for intracellular signaling. Partial β-catenin nuclear translocation was also observed in 
response to tensile strain [27]. Furthermore, there was an additive effect of load and Wnt3a 
on β-catenin translocation and on up-regulation of Mmp-3 gene expression [27]. Of interest, a 
down-regulation of FrzB was observed in human and mouse cartilage explants in response to 
mechanical injury, suggesting a de-repression of canonical Wnt pathway [46]. Thus, Wnt/β-
catenin signaling may be part of the signaling response leading to excessive catabolism and 
cartilage degradation in response to abnormal loading and FrzB may have a protective role on 
load-induced increase in MMP activity. 
Enhanced responsiveness to IL-1β in absence of FrzB and involvement of 
canonical Wnt/β-catenin pathway 
We demonstrated that IL-1β-mediated increases in Mmp-3 and −13 gene expression and 
protein release were enhanced in FrzB−/− chondrocytes. Similarly, IL-1β stimulated Ctnnb1 
and Lef1 gene expression and β-catenin accumulation in FrzB−/− chondrocytes. Canonical 
Wnt pathway activation may thus enhance chondrocyte responsiveness to IL-1β. These 
results suggest a crosstalk between the canonical Wnt pathway, which includes β-catenin and 
FrzB, and IL-1 pathway, which stimulates MMP expression in chondrocytes. In accordance 
with our results, activation of β-catenin signaling in cultured chondrocytes by Wnt3a 
treatment potentiated IL-1β-mediated loss of proteoglycans [25]. Conversely, inhibition of β-
catenin signaling by the use of Lef1 siRNA down-regulated IL-1β-mediated increase in Mmp-
13 gene expression [29]. Also, Sost, which is a biologically active inhibitor of β-catenin 
signaling in chondrocytes, down-regulated IL-1α-mediated increase in Mmp-13 gene 
expression in cartilage explants and also reduced the loss of proteoglycans [47]. An 
alternative suggestion is that IL-1β treatment may induce canonical Wnt production, such as 
Wnt-7b, which in turn could activate β-catenin signaling [48]. In surprising contrast, in 
human chondrocytes, β-catenin signaling was found to counteract IL-1β-mediated increase in 
MMP-3 and −13 expressions [48]. In conclusion, canonical Wnt pathway may be part of 
mechanisms leading to excessive catabolism in response to inflammatory stress and FrzB 
may have a protective role on IL-1-mediated increase in MMP expression in mouse 
chondrocytes. 
Putative protective role of FrzB in OA progression 
In osteoarthritis (OA), cartilage breakdown is due to cleavages of matrix molecules in 
response to abnormal mechanical stress and to some degree of inflammation. Because our 
results suggest that FrzB may have a protective role on load- and IL-1-mediated catabolic 
processes in mouse chondrocytes, we speculate that FrzB may have a protective role in OA. 
Our results are consistent with the increased cartilage loss observed in models of arthritis in 
FrzB−/− knockout mice [18]. Moreover, gene expression of Mmp-3 was up-regulated in the 
cartilage of FrzB−/− mice with mBSA-induced arthritis compared with wild-type mice. 
However, FrzB−/− knockout mice did not develop spontaneous OA, and they did not show 
aberrant Mmp gene expressions in basal conditions, except a 2-fold increase for MMP-3 [36]. 
Thus, FrzB may be involved in OA progression rather than OA onset. Although FrzB may 
interact directly with MMP-3 [18], its protective role is probably linked with a deregulation 
of the Wnt pathways. The recent identification of FrzB as a blocker of hypertrophic 
differentiation in articular cartilage [22], promote the hypothesis of a protective role of FrzB 
in OA through the Wnt-mediated regulation of hypertrophic maturation. 
Conclusions 
Our results suggest that FrzB has a protective role on MMP induction in mouse chondrocytes. 
They indicate a dual role of Wnt signaling in cartilage homeostasis, so that a controlled 
amount of Wnt signaling is necessary for maintenance of the articular cartilage, but an excess 
one is deleterious. Further investigations are needed to decipher the tight control of Wnt 
signaling in OA, in particular concerning the differentiation of OA chondrocytes towards 
hypertrophy. 
Our results also add evidence to demonstrate that the canonical Wnt/β-catenin pathway is part 
of mechanisms leading to excessive catabolism and cartilage degradation in OA. However, 
the FrzB-dependent deregulation that we observed may involve both canonical and non-
canonical Wnt signaling since FrzB is an inhibitor of both pathways. Little is known 
concerning the role of non-canonical Wnt pathway in articular cartilage homeostasis and OA 
development. Recent data suggested that, in excess, Wnt5a could stimulate degradation of 
mature cartilage matrix via non-canonical pathways, while promoting normal differentiation 
in developing cartilage [49]. Therefore, additional investigations on Wnt regulation in OA 
should equally explore canonical and non-canonical Wnt pathways. 
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